首页> 外文期刊>Nature >Structure of active p-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide
【24h】

Structure of active p-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide

机译:活性p-arrestin-1与G蛋白偶联受体磷酸肽结合的结构

获取原文
获取原文并翻译 | 示例
           

摘要

The functions of G-protein-coupled receptors (GPCRs) are primarily mediated and modulated by three families of proteins: the heterotrimeric G proteins, the G-protein-coupled receptor kinases (GRKs) and the arrestins. G proteins mediate activation of second-messenger-generating enzymes and other effectors, GRKs phos-phorylate activated receptors, and arrestins subsequently bind phosphorylated receptors and cause receptor desensitization3. Arrestins activated by interaction with phosphorylated receptors can also mediate G-protein-independent signalling by serving as adaptors to link receptors to numerous signalling pathways4. Despite their central role in regulation and signalling of GPCRs, a structural understanding of P-arrestin activation and interaction with GPCRs is still lacking. Here we report the crystal structure of β-arrestin-1 (also called arrestin-2) in complex with a fully phosphorylated 29-amino-acid carboxy-terminal peptide derived from the human V2 vasopressin receptor (V2Rpp). This peptide has previously been shown to functionally and conformationally activate β-arrestin-1 (ref. 5). To capture this active conformation, we used a conformationally selective synthetic antibody fragment (Fab30) that recognizes the phosphopeptide-activated state of β-arrestin-1. The structure of the P-arrestin-1-V2Rpp-Fab30 complex shows marked conformational differences in β-arrestin-1 compared to its inactive conformation. These include rotation of the amino-and carboxy-terminal domains relative to each other, and a major reorientation of the 'lariat loop' implicated in maintaining the inactive state of β-arrestin-1. These results reveal, at high resolution, a receptor-interacting interface on P-arrestin, and they indicate a potentially general molecular mechanism for activation of these multifunctional signalling and regulatory proteins.
机译:G蛋白偶联受体(GPCR)的功能主要由三个蛋白家族介导和调节:异三聚体G蛋白,G蛋白偶联受体激酶(GRKs)和抑制蛋白。 G蛋白介导第二信使产生酶和其他效应子(GRKs磷酸磷酸酯活化的受体)的激活,而抑制蛋白随后结合磷酸化的受体并引起受体脱敏3。通过与磷酸化受体相互作用而激活的arrestin还可以充当衔接子,将受体连接到许多信号通路上,从而介导G蛋白非依赖性信号传导4。尽管它们在GPCR的调控和信号转导中起着中心作用,但仍缺乏对P-arrestin活化以及与GPCR相互作用的结构性理解。在这里,我们报道了与人V2加压素受体(V2Rpp)衍生的完全磷酸化的29个氨基酸的羧基末端肽复合的β-arrestin-1(也称为restarin-2)的晶体结构。先前已显示该肽在功能和构象上激活β-arrestin-1(参考文献5)。为了捕获该活性构象,我们使用了构象选择性的合成抗体片段(Fab30),该片段识别β-arrestin-1的磷酸肽激活状态。与无活性构象相比,P-arrestin-1-V2Rpp-Fab30复合物的结构在β-arrestin-1中显示出明显的构象差异。这些包括氨基和羧基末端结构域相对于彼此的旋转,以及牵涉到维持β-arrestin-1失活状态的“ lariat环”的主要重新定向。这些结果在高分辨率下揭示了P-arrestin上的受体相互作用界面,它们表明了激活这些多功能信号和调节蛋白的潜在一般分子机制。

著录项

  • 来源
    《Nature》 |2013年第7447期|137-141A5|共6页
  • 作者单位

    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA;

    Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California 94305,USA;

    Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California 94305,USA;

    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA;

    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA;

    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA;

    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA;

    Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California 94305,USA;

    Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois 60637, USA;

    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA;

    Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois 60637, USA;

    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA;

    Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois 60637, USA;

    Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois 60637, USA;

    Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California 94305,USA,Department of Structural Biology, Stanford University School of Medicine, Stanford,California 94305, USA;

    Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois 60637, USA;

    Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California 94305,USA;

    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.,Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois 60637, USA,Department of Biochemistry, Duke University Medical Center, Durham;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号